Here is What Institutional Investors Think About Exact Sciences Corp (NASDAQ:EXAS)

July 18, 2017 - By Marguerite Chambers

 Here is What Institutional Investors Think About Exact Sciences Corp (NASDAQ:EXAS)

Sentiment for Exact Sciences Corp (NASDAQ:EXAS)

Exact Sciences Corp (NASDAQ:EXAS) institutional sentiment decreased to 1.08 in 2016 Q4. Its down -0.40, from 1.48 in 2016Q3. The ratio worsened, as 98 active investment managers increased and opened new stock positions, while 91 sold and reduced their equity positions in Exact Sciences Corp. The active investment managers in our partner’s database now possess: 88.31 million shares, up from 87.34 million shares in 2016Q3. Also, the number of active investment managers holding Exact Sciences Corp in their top 10 stock positions decreased from 3 to 2 for a decrease of 1. Sold All: 35 Reduced: 56 Increased: 67 New Position: 31.

Exact Sciences Corporation is a molecular diagnostics company. The company has market cap of $4.54 billion. The Firm focuses on the early detection and prevention of some forms of cancer. It currently has negative earnings. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer.

The stock increased 0.13% or $0.05 during the last trading session, reaching $38.64. About shares traded. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since July 18, 2016 and is uptrending. It has outperformed by 441.54% the S&P500.

Analysts await EXACT Sciences Corporation (NASDAQ:EXAS) to report earnings on July, 25. They expect $-0.37 earnings per share, up 19.57 % or $0.09 from last year’s $-0.46 per share. After $-0.32 actual earnings per share reported by EXACT Sciences Corporation for the previous quarter, Wall Street now forecasts 15.63 % negative EPS growth.

Sanctuary Wealth Advisors Llc holds 2.88% of its portfolio in EXACT Sciences Corporation for 242,715 shares. Shannon River Fund Management Llc owns 550,000 shares or 2.29% of their US portfolio. Moreover, Thompson Investment Management Inc. has 1.57% invested in the company for 600,294 shares. The China-based J&P(China)Capital Management Co.Ltd has invested 1.54% in the stock. Zevenbergen Capital Investments Llc, a Washington-based fund reported 2.33 million shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 9 insider sales for $1.67 million activity.

EXACT Sciences Corporation (NASDAQ:EXAS) Ratings Coverage

Ratings analysis reveals 57% of EXACT Sciences’s analysts are positive. Out of 14 Wall Street analysts rating EXACT Sciences, 8 give it “Buy”, 1 “Sell” rating, while 5 recommend “Hold”. The lowest target is $4 while the high is $5000. The stock’s average target of $27.86 is -27.90% below today’s ($38.64) share price. EXAS was included in 40 notes of analysts from July 24, 2015. Roth Capital maintained the stock with “Buy” rating in Tuesday, October 6 report. On Tuesday, October 6 the stock rating was maintained by TH Capital with “Buy”. TH Capital maintained EXACT Sciences Corporation (NASDAQ:EXAS) rating on Friday, October 30. TH Capital has “Buy” rating and $12 target. BTIG Research initiated it with “Buy” rating and $14 target in Friday, December 18 report. The firm earned “Buy” rating on Wednesday, July 27 by Jefferies. Lake Street maintained it with “Hold” rating and $7 target in Tuesday, November 24 report. Roth Capital maintained it with “Buy” rating and $12 target in Friday, October 30 report. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) has “Buy” rating given on Tuesday, July 4 by Jefferies. The company was maintained on Wednesday, October 7 by Canaccord Genuity. The firm has “Buy” rating given on Thursday, July 6 by Craig Hallum.

More important recent EXACT Sciences Corporation (NASDAQ:EXAS) news were published by: which released: “Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening” on June 22, 2017, also published article titled: “Exact Sciences to host second-quarter 2017 results, annual meeting webcasts …”, published: “Why Exact Sciences Corp. Fell 7.5% In June” on July 07, 2017. More interesting news about EXACT Sciences Corporation (NASDAQ:EXAS) was released by: and their article: “Why Exact Sciences (EXAS) Could Beat Earnings Estimates Again” with publication date: June 28, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.